Sumitomo Pharma Co., Ltd. (TYO:4506)

Market Cap	803.32B +188.9%
Revenue (ttm)	453.40B +21.6%
Net Income	110.09B
EPS	277.11
Shares Out	397.29M
PE Ratio	7.30
Forward PE	9.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,438,000
Average Volume	10,035,205
Open	2,039.50
Previous Close	2,018.50
Day's Range	1,977.00 - 2,056.00
52-Week Range	500.00 - 3,288.00
Beta	0.60
RSI	47.84
Earnings Date	May 13, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4506